In the US, Apidra SoloStar (insulin glulisine systemic) is a member of the drug class insulin and is used to treat Diabetes - Type 1, Diabetes - Type 2, Diabetic Ketoacidosis and Nonketotic Hyperosmolar Syndrome.
Ingredient matches for Apidra SoloStar
Insulin Glulisine is reported as an ingredient of Apidra SoloStar in the following countries:
- New Zealand
- South Korea
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.